[article]
| Titre : |
Prevalence and treatment of autism spectrum disorder in the United States, 2016-2022 |
| Type de document : |
texte imprimé |
| Auteurs : |
Wen-Qiang HE, Auteur |
| Article en page(s) : |
p.1916-1927 |
| Langues : |
Anglais (eng) |
| Mots-clés : |
ASD prevalence COVID-19 pandemic geographical region variation medication treatment |
| Index. décimale : |
PER Périodiques |
| Résumé : |
Abstract This study aims to assess the prevalence of Autism Spectrum Disorder (ASD) and its treatment. The study population was children aged 3 17 years with information on current ASD from National Survey of Children's Health, 2016 2022. Analysis of treatment was also conducted within the population of children with a current ASD diagnosis. A multivariate log-binomial regression model was used to assess the change of current ASD prevalence and ASD treatment by two study period (prior to COVID-19 pandemic: 2016 2019; during COVID-19 pandemic: 2020 22) and sociodemographic information. Compared to the current ASD at 2.5% in 2016, it increased to 3.6% in 2022. The treatment has decreased from 70.5% in 2016 to 61.6% in 2022 for any treatment and from 27.2% in 2016 to 20.4% in 2022 for medication treatment. Compared to children from 2016 2019, children from the following group were more likely to have ASD diagnosis during the pandemic (2020 2022), including those aged 3 5 years (aPR 1.66, 95%CI 1.29 2.13), non-Hispanic white children, children from family with above national family income, and those with private insurance. However, medication treatment almost halved during the pandemic for non-Hispanic black children (aPR 0.49, 95%CI 0.26 0.93) and children born overseas. In conclusion, higher prevalence of ASD might indicate a better awareness of ASD. The reduction in treatment correlates to the health service disruption caused by the pandemic, highlighting the needs of policy efforts to improve treatment for ASD. |
| En ligne : |
https://doi.org/10.1002/aur.3228 |
| Permalink : |
https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=535 |
in Autism Research > 17-9 (September 2024) . - p.1916-1927
[article] Prevalence and treatment of autism spectrum disorder in the United States, 2016-2022 [texte imprimé] / Wen-Qiang HE, Auteur . - p.1916-1927. Langues : Anglais ( eng) in Autism Research > 17-9 (September 2024) . - p.1916-1927
| Mots-clés : |
ASD prevalence COVID-19 pandemic geographical region variation medication treatment |
| Index. décimale : |
PER Périodiques |
| Résumé : |
Abstract This study aims to assess the prevalence of Autism Spectrum Disorder (ASD) and its treatment. The study population was children aged 3 17 years with information on current ASD from National Survey of Children's Health, 2016 2022. Analysis of treatment was also conducted within the population of children with a current ASD diagnosis. A multivariate log-binomial regression model was used to assess the change of current ASD prevalence and ASD treatment by two study period (prior to COVID-19 pandemic: 2016 2019; during COVID-19 pandemic: 2020 22) and sociodemographic information. Compared to the current ASD at 2.5% in 2016, it increased to 3.6% in 2022. The treatment has decreased from 70.5% in 2016 to 61.6% in 2022 for any treatment and from 27.2% in 2016 to 20.4% in 2022 for medication treatment. Compared to children from 2016 2019, children from the following group were more likely to have ASD diagnosis during the pandemic (2020 2022), including those aged 3 5 years (aPR 1.66, 95%CI 1.29 2.13), non-Hispanic white children, children from family with above national family income, and those with private insurance. However, medication treatment almost halved during the pandemic for non-Hispanic black children (aPR 0.49, 95%CI 0.26 0.93) and children born overseas. In conclusion, higher prevalence of ASD might indicate a better awareness of ASD. The reduction in treatment correlates to the health service disruption caused by the pandemic, highlighting the needs of policy efforts to improve treatment for ASD. |
| En ligne : |
https://doi.org/10.1002/aur.3228 |
| Permalink : |
https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=535 |
|  |
Faire une suggestion Affiner la recherchePrevalence and treatment of autism spectrum disorder in the United States, 2016-2022 / Wen-Qiang HE in Autism Research, 17-9 (September 2024)
